P170003/S029: Lutonix 018 Drug Coated Balloon PTA Catheter
FDA’s recorded scope: Approval for a change in the paclitaxel (PTx) active pharmaceutical ingredient (API) supplier.
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Lutonix. 2 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 4, 2025 to Jul 9, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code ONU appears in 2 of the 4 linked filings. The collection spans 2 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P130024, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 9409 Science Center Dr., New Hope, MN, 55428. Recorded on P170003/S029, decision dated Jul 9, 2026.
Drug-coated peripheral transluminal angioplasty catheter; Drug-Eluting Peripheral Transluminal Angioplasty Catheter.
FDA’s recorded scope: Approval for a change in the paclitaxel (PTx) active pharmaceutical ingredient (API) supplier.
FDA’s recorded scope: Approval for a change in the paclitaxel (PTx) active pharmaceutical ingredient (API) supplier.
FDA’s recorded scope: reducing the frequency of residual solvent testing from every individual lot to a single lot per month
FDA’s recorded scope: reducing the frequency of residual solvent testing from every individual lot to a single lot per month
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Lutonix 018 Drug Coated Balloon PTA CatheterP170003/S029 | Lutonix | PMA supplement | Jul 9, 2026 | FDA |
Lutonix 035 Drug Coated Balloon CatheterP130024/S045 | Lutonix | PMA supplement | Jul 9, 2026 | FDA |
Lutonix 018 (Model 9014)P170003/S028 | Lutonix | PMA supplement | Sep 4, 2025 | FDA |
Lutonix 035 (Model 9004 and Model 9010)P130024/S044 | Lutonix | PMA supplement | Sep 4, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.